NEW YORK (Reuters) - Roche Holding AG's (ROG.VX: Quote, Profile, Research, Stock Buzz) chief executive said the drugmaker maintains its full-year forecast of double-digit sales growth for drugs and the group as a whole.
"We've said our guidance for the full year stays the same; that has not changed," Franz Humer told the Reuters Health Summit in New York.
"We've said we'll grow sales double-digit in pharma, and for the group, we'll outgrow the market in both divisions and EPS is going to grow faster than sales. We continue to stick with that," Humer said.
Roche also still plans to raise its dividend payout ratio, Humer said, but did not give a specific percentage goal for payouts to shareholders.
(For summit blog: summitnotebook.reuters.com/)
(Reporting by Sam Cage, editing by Gerald E. McCormick)
© Thomson Reuters 2009. All rights reserved.
| Health | Nov 09 - 12, 2009 | Health |
| Autos | Nov 02 - 4, 2009 | Autos |
| Middle East Investment | Oct 26 - 28, 2009 | Country Summits |
| Washington | Oct 19 - 21, 2009 | Country Summits |
| Global Wealth Management | Oct 05 - 7, 2009 | Financial Services / Exchanges |
